Simplex Trading
PPBT

Simplex Trading’s Purple Biotech PPBT Stock Holding History

Simplex Trading’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-200
Closed -$808 – 10099
2026
Q1 		$808 Buy
200
+180
+900% +$971 ﹤0.01% 8644
2025
Q4 		$131 Buy
+20
New +$145 ﹤0.01% 8288
2025
Q1 		– Sell
-140
Closed -$6K – 9401
2024
Q4 		$6K Buy
+140
New +$5.39K ﹤0.01% 7524
2022
Q3 		– Sell
-18
Closed -$8K – 10668
2022
Q2 		$8K Sell
18
-17
-49% -$10.2K ﹤0.01% 8490
2022
Q1 		$27K Sell
35
-67
-66% -$43.2K ﹤0.01% 7903
2021
Q4 		$78K Buy
102
+100
+5,000% +$85.2K ﹤0.01% 6629
2021
Q3 		$1K Hold
2
– – ﹤0.01% 9674
2021
Q2 		$1K Buy
+2
New +$1.84K ﹤0.01% 9853
2021
Q1 		– Hold
0
– – – 8287
2020
Q4 		– Hold
0
– – – 7997

Other funds holding PPBT

SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Simplex Trading's PPBT Position: Q2 2026 in Review

Simplex Trading sold out of Purple Biotech (PPBT) in Q2 2026, closing a stake of 597 shares — an estimated $2.01K sold.

Simplex Trading first reported a position in PPBT in Q4 2020 and held it in 13 quarters. The position peaked at $34K in Q1 2023. 13 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

  • Simplex Trading reported no remaining Purple Biotech position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 597 Purple Biotech shares in Q2 2026, an estimated $2.01K.
  • Simplex Trading first reported a position in Purple Biotech in Q4 2020 and held it in 13 quarters.
  • Simplex Trading's Purple Biotech position peaked at $34K in Q1 2023.
  • 13 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.